首页> 外文期刊>American Journal of Transplantation >Immunosuppression, Generic Drugs and the FDA
【24h】

Immunosuppression, Generic Drugs and the FDA

机译:免疫抑制,仿制药和FDA

获取原文
获取原文并翻译 | 示例
           

摘要

No abstract is available for this article.
机译:本文没有摘要。

著录项

  • 来源
    《American Journal of Transplantation》 |2012年第3期|792-793|共2页
  • 作者单位

    Department of Pharmacy Hospital of the University of Pennsylvania Philadelphia PA;

    Renal Electrolyte and Hypertension Division Perelman School of Medicine University of Pennsylvania Philadelphia PA;

    Abdominal Organ Transplant Departments of Transplant Surgery/Renal Division and Pharmacy Services Brigham and Women's Hospital Boston MA;

    Department of Medicine Harvard Medical School Boston MA;

    Organ Transplantation Tufts Medical Center Boston MA;

    Tufts University School of Medicine Boston MA;

    Transplant Clinical Research Division of Transplantation Department of Nephrology University of Cincinnati Cincinnati OH;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号